Prognostic and immunomodulatory consequences of ERV expression in ovarian cancer

Dataset ID Technology Samples
EGAD00001006589 N/A 79

Dataset Description

The dataset contains transcriptional data obtained using total RNA sequencing on a Illumina machin. 59 samples are from the Hammersmith Hospital (HH) cohort of human primary ovarian tumours and 20 samples are from ovarian cancer cell lines Kuramochi (3 replicates) and Ovsaho (2 replicates) treated with 1 uM DNMTi guadecitabine or vehicle, at an early (day 5) or late (day 8) timepoint.

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

Imperial College Tumour Immunology group - Surgery and Cancer DAC
Contact person: Sadaf Ghaem-Maghami
Email: s [dot] ghaem-maghami [at] imperial [dot] ac [dot] uk
More details: EGAC00001001814


You don't have access to the download section.